Diagnosis and Staging

  • Andrew J. M. Boulton
  • Loretta Vileikyte


The diagnosis of diabetic neuropathy largely depends on a careful clinical examination that should be preceded by a history, which can be difficult and time-consuming. History-taking can also be confounded by the inability of some patients to communicate unusual sensations (see below) and difficulty in separating out multiple symptoms.


Diabetic Neuropathy Quantitative Sensory Testing Chronic Inflammatory Demyelinating Polyneuropathy Brief Pain Inventory Cardiovascular Autonomic Neuropathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Haythornthwaite JA, Benrud-Larson LM. Psychological assessment and treatment of patients with neuropathic pain. Curr Pain Headache Rep. 2001;5:124-129.PubMedCrossRefGoogle Scholar
  2. 2.
    Backonja MM, Galer BS. Pain assessment and evaluation of patients who have neuropathic pain. Neurol Clin. 1998;16:775-790.PubMedCrossRefGoogle Scholar
  3. 3.
    Huskisson EC. Measurement of pain. Lancet. 1974;2:1127-1131.PubMedCrossRefGoogle Scholar
  4. 4.
    Teng JM, Mekhail NM. Neuropathic pain: mechanisms and treatment options. Pain Practice. 2003;3:8-21.CrossRefGoogle Scholar
  5. 5.
    Hansson P. Neuropathic pain: clinical characteristics and diagnostic workup. Eur J Pain. 2002;6(suppl A):47-50.PubMedCrossRefGoogle Scholar
  6. 6.
    Apfel SC, Asbury AK, Bril V, et al. Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci. 2001;189:3-5.PubMedCrossRefGoogle Scholar
  7. 7.
    Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1:277-299.PubMedCrossRefGoogle Scholar
  8. 8.
    Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30:191-197.PubMedCrossRefGoogle Scholar
  9. 9.
    Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129-138.PubMedGoogle Scholar
  10. 10.
    Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology. 1997;48:332-338.PubMedGoogle Scholar
  11. 11.
    Galer BS, Jensen MP, Ma T, et al. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain. 2002;18:297-301.PubMedCrossRefGoogle Scholar
  12. 12.
    Bennett M. The LANSS Pain Scale: the Leeds assessment symptoms and signs. Pain. 2001;92:147-157.PubMedCrossRefGoogle Scholar
  13. 13.
    Vileikyte L, Peyrot M, Bundy C, et al. The development and validation of a neuropathy and foot ulcer specific quality of life rate. Diab Care. 2003;26:2549-2555.CrossRefGoogle Scholar
  14. 14.
    Young MJ, Boulton AJM, MacLeod AF, et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150-154.PubMedCrossRefGoogle Scholar
  15. 15.
    Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia. 1998;41:1263-1269.PubMedCrossRefGoogle Scholar
  16. 16.
    Feldman EL, Stevens MJ, Thomas PK, et al. A practice two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diab Care. 1994;17:1281-1289.CrossRefGoogle Scholar
  17. 17.
    Meijer JW, Smit AJ, Sondersen EV, et al. Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom Score. Diabet Med. 2002;19:962-965.PubMedCrossRefGoogle Scholar
  18. 18.
    Valk GD, Nauta JJP, Strijem RLM, et al. Clinical examination versus neurophysiological examination in the diagnosis of diabetic polyneuropathy. Diabet Med. 1992;9:716-721.PubMedCrossRefGoogle Scholar
  19. 19.
    Boulton AJM, Malik RA, Arezzo JC, et al. Diabetic somatic neuropathies. Diab Care. 2004;27:1458-1486.CrossRefGoogle Scholar
  20. 20.
    Greenspan JD. Quantitative assessment of neuropathic pain. Curr Pain Headache Rep. 2001;5:107-113.PubMedCrossRefGoogle Scholar
  21. 21.
    Arezzo JC. Quantitative sensory testing. In: Gris FA, Cameron NE, Low PA, et al., eds. Textbook of Diabetic Neuropathy. Stuttgart: Thième; 2003:184-189.Google Scholar
  22. 22.
    Shy ME, Frohman EM, So YT, et al. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003;60:898-904.PubMedGoogle Scholar
  23. 23.
    Vinik AI, Erbas T, Pfiefer M, et al. Diabetic autonomic neuropathy. In: Inzucchi SE, ed. The Diabetes Mellitus Manual: A primary Care Companion to Ellenberg and Rifkin’s. 6th ed. New York: McGraw Hill; 2004:351.Google Scholar
  24. 24.
    Boulton AJM, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diab Care. 2005;28:956-962.CrossRefGoogle Scholar
  25. 25.
    Boulton AJM, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med. 1998;15:508-514.PubMedCrossRefGoogle Scholar
  26. 26.
    Dyck PJ. Severity and staging of diabetic polyneuropathy. In: Gris FA, Cameron NE, Low PA, et al., eds. Textbook of Diabetic Neuropathy. Stuttgart: Thième; 2003:170-175.Google Scholar
  27. 27.
    Dyck PJ, Dyck PJB. Diabetic polyneuropathy: section II. In: Dyck PJ, Thomas PK, eds. Diabetic Neuropathy. 2nd ed. Philadelphia: W.B. Saunders; 1999:255-278.Google Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  • Andrew J. M. Boulton
    • 1
    • 2
  • Loretta Vileikyte
    • 1
    • 3
  1. 1.University of ManchesterManchesterUK
  2. 2.Diabetes Research InstituteUniversity of MiamiMiamiUSA
  3. 3.University of MiamiMiamiUSA

Personalised recommendations